Smart pump study aims to reduce dangerous lows in diabetes
NCT ID NCT03047486
First seen Apr 08, 2026 · Last updated May 12, 2026 · Updated 5 times
Summary
This study looked at how well a smart insulin pump system (Smartguard) works in daily life for adults with type 1 diabetes. The system automatically stops insulin delivery when it predicts a low blood sugar. Thirty participants used the system for one year, and researchers tracked their blood sugar control and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS MATURITY ONSET are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen
Caen, 14000, France
Conditions
Explore the condition pages connected to this study.